Maculopapular rash


A maculopapular rash develops on the skin as a red, flat patch covered with small bumps. It may not appear as red on dark-skinned people. This is commonly due to viral infection or can be an allergic reaction, especially that of chemotherapy drugs. Antibiotic amoxicillin reaction and bacterial infection can also be maculopapular rash causes.

The maculopapular rash look like red flat lesions with small raised bumps, that can last from 2 to 21 days. Red color on skin is not visible for dark-complexioned ones.

The formation of the papular rash can be due to many reasons. It is important to understand the cause to do the treatment. To confirm the cause, consult a dermatologist. Usually, over-the-counter drugs, medicines to relieve itching, topical steroids and antihistamines are prescribed.

Amoxicillin rash is exhibited as hives that will look like white or red bumps on the skin. Sometimes the maculopapular rash can also appear like the same. Maculopapular rashes in babies are complicated and thus requires immediate medical attention.

An antibiotic rash can look like red, flat patches sometimes exhibited like hives. An antibiotic rash occurs due to the reaction to any antibiotic drug or penicillin family drugs. It can sometimes become intense rashes with hives too.

The papular rash means small raised bumps. The maculopapular rash looks like red flat lesions of small raised bumps. In some cases, a maculopapular rash with fever can occur as symptoms of an intense allergic reaction.

Find more symptoms

Stretch marks

Symptoms Stretch marks Overview As the name suggests Stretch marks or Striae are lines or stripes

Nail Discoloration

Symptoms Nail Discoloration Overview If your nail appears yellow, green or white then it is called

Darkening of skin

Symptoms Darkening of skin Overview Skin darkening is common among people and Hyperpigmentation is the term


At one place know the best information on various cancer drugs and common symptoms associated.

CANKADO’s PRO-react Onco helps efficient patient physician communication in the treatment phase.


© 2021 Cancer.Cankado. All rights Reserved

CANKADO is approved as an active Class I medical device within the European Union (registration number DE/CA59/11976/2017) and is compliant with the FDA classification for Mobile Medical Devices (2015) Appendix B.

Auto Translate »

CANKADO processes information about your visit on this website using cookies. These are required to ensure the correct functionality of the homepage, to improve its performance and our third-party services. These services cannot be used without your consent.